These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 32701908)

  • 1. Statistics Commentary Series. Commentary No. 42: Minimization.
    Streiner DL
    J Clin Psychopharmacol; 2020; 40(5):441-442. PubMed ID: 32701908
    [No Abstract]   [Full Text] [Related]  

  • 2. Statistics Commentary Series. Commentary No. 41: Randomization.
    Streiner DL
    J Clin Psychopharmacol; 2020; 40(5):439-440. PubMed ID: 32773494
    [No Abstract]   [Full Text] [Related]  

  • 3. Design optimization for dose-finding trials: a review.
    Aouni J; Bacro JN; Toulemonde G; Colin P; Darchy L; Sebastien B
    J Biopharm Stat; 2020 Jul; 30(4):662-673. PubMed ID: 32183578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Response adaptive randomization procedures in seamless phase II/III clinical trials.
    Zhu H; Piao J; Lee JJ; Hu F; Zhang L
    J Biopharm Stat; 2020; 30(1):3-17. PubMed ID: 31454295
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-trend impact on treatment estimation in two-arm clinical trials with a binary outcome and Bayesian response adaptive randomization.
    Jiang Y; Zhao W; Durkalski-Mauldin V
    J Biopharm Stat; 2020; 30(1):69-88. PubMed ID: 31017843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statistics Commentary Series. Commentary No. 43: Patient Preference Trials.
    Streiner DL
    J Clin Psychopharmacol; 2020; 40(6):529-530. PubMed ID: 33044357
    [No Abstract]   [Full Text] [Related]  

  • 7. Modified Goldilocks Design with strict type I error control in confirmatory clinical trials.
    Zhan T; Zhang H; Hartford A; Mukhopadhyay S
    J Biopharm Stat; 2020 Sep; 30(5):821-833. PubMed ID: 32297825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statistics Commentary Series. Commentary No. 44: Internal and External Validity.
    Streiner DL
    J Clin Psychopharmacol; 2020; 40(6):531-533. PubMed ID: 33044353
    [No Abstract]   [Full Text] [Related]  

  • 9. A response adaptive design for ordinal categorical responses.
    Biswas A; Bhattacharya R; Das S
    J Biopharm Stat; 2018; 28(6):1169-1181. PubMed ID: 29504826
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two-stage adaptive enrichment design for testing an active factor.
    Ding AA; Wu SS; Dean NE; Zahigian RS
    J Biopharm Stat; 2020; 30(1):18-30. PubMed ID: 31135263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptive trials for tuberculosis: early reflections on theory and practice.
    Montgomery CM
    Int J Tuberc Lung Dis; 2016 Aug; 20(8):1091-8. PubMed ID: 27393545
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Guided by the research design: choosing the right statistical test.
    Beath A; Jones MP
    Med J Aust; 2018 Mar; 208(4):163-165. PubMed ID: 29490219
    [No Abstract]   [Full Text] [Related]  

  • 13. Mixture-based gatekeeping procedures in adaptive clinical trials.
    Kordzakhia G; Dmitrienko A; Ishida E
    J Biopharm Stat; 2018; 28(1):129-145. PubMed ID: 29283310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of proper conduct of clinical trials.
    Cortegiani A; Absalom AR
    Br J Anaesth; 2021 Feb; 126(2):354-356. PubMed ID: 33121749
    [No Abstract]   [Full Text] [Related]  

  • 15. Multi-arm multi-stage trials can improve the efficiency of finding effective treatments for stroke: a case study.
    Jaki T; Wason JMS
    BMC Cardiovasc Disord; 2018 Nov; 18(1):215. PubMed ID: 30482176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confirmatory clinical trials with an adaptive design.
    Koch A
    Biom J; 2006 Aug; 48(4):574-85. PubMed ID: 16972708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lies, damn lies, and statistics.
    Yentis SM
    Anaesthesia; 2012 May; 67(5):455-456. PubMed ID: 22404377
    [No Abstract]   [Full Text] [Related]  

  • 18. On statistical methods to test if sampling in trials is genuinely random.
    Pandit JJ
    Anaesthesia; 2012 May; 67(5):456-462. PubMed ID: 22404285
    [No Abstract]   [Full Text] [Related]  

  • 19. Is Propensity Score Analysis a Valid Surrogate of Randomization for the Avoidance of Allocation Bias?
    Torres F; Ríos J; Saez-Peñataro J; Pontes C
    Semin Liver Dis; 2017 Aug; 37(3):275-286. PubMed ID: 28847037
    [No Abstract]   [Full Text] [Related]  

  • 20. ALS issues in clinical trials. Missing data.
    Thompson JL; Levy G
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2004 Sep; 5 Suppl 1():48-51. PubMed ID: 15512872
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.